<?xml version='1.0' encoding='utf-8'?>
<document id="27196356"><sentence text="Drug Interactions with Cobicistat- or Ritonavir-Boosted Elvitegravir."><entity charOffset="56-68" id="DDI-PubMed.27196356.s1.e0" text="Elvitegravir" /></sentence><sentence text="Cobicistat and ritonavir are structurally distinct compounds that both potently inhibit cytochrome P450 (CYP) 3A, the metabolizing enzyme primarily responsible for the elimination of several antiretroviral medications, and, as such, are pharmacokinetic boosters for antiretroviral agents that require longer dosing intervals"><entity charOffset="15-24" id="DDI-PubMed.27196356.s2.e0" text="ritonavir" /></sentence><sentence text=" Recently, cobicistat was approved for the treatment of HIV-1 infection in treatment-naive adults as a component of a single-tablet regimen consisting of cobicistat-boosted elvitegravir plus emtricitabine and tenofovir disoproxil fumarate"><entity charOffset="173-185" id="DDI-PubMed.27196356.s3.e0" text="elvitegravir" /><entity charOffset="191-204" id="DDI-PubMed.27196356.s3.e1" text="emtricitabine" /><entity charOffset="209-238" id="DDI-PubMed.27196356.s3.e2" text="tenofovir disoproxil fumarate" /><pair ddi="false" e1="DDI-PubMed.27196356.s3.e0" e2="DDI-PubMed.27196356.s3.e0" /><pair ddi="false" e1="DDI-PubMed.27196356.s3.e0" e2="DDI-PubMed.27196356.s3.e1" /><pair ddi="false" e1="DDI-PubMed.27196356.s3.e0" e2="DDI-PubMed.27196356.s3.e2" /><pair ddi="false" e1="DDI-PubMed.27196356.s3.e1" e2="DDI-PubMed.27196356.s3.e1" /><pair ddi="false" e1="DDI-PubMed.27196356.s3.e1" e2="DDI-PubMed.27196356.s3.e2" /></sentence><sentence text=" While studies have demonstrated that boosting with either cobicistat or ritonavir results in comparable plasma exposure of the target antiretroviral agent, a better understanding of drug-drug interactions between cobicistat- and ritonavir-boosted antiretrovirals and other medications will inform treatment decisions in HIV-infected patients"><entity charOffset="73-82" id="DDI-PubMed.27196356.s4.e0" text="ritonavir" /><entity charOffset="230-239" id="DDI-PubMed.27196356.s4.e1" text="ritonavir" /><pair ddi="false" e1="DDI-PubMed.27196356.s4.e0" e2="DDI-PubMed.27196356.s4.e0" /><pair ddi="false" e1="DDI-PubMed.27196356.s4.e0" e2="DDI-PubMed.27196356.s4.e1" /></sentence><sentence text=" In connection with their distinct structural properties, COBI and RTV differ with respect to their drug-drug interaction profiles" /><sentence text=" Compared with ritonavir, cobicistat lacks induction potential and is a more specific inhibitor of 3A and therefore, has reduced effects on other CYP isoforms"><entity charOffset="15-24" id="DDI-PubMed.27196356.s6.e0" text="ritonavir" /></sentence><sentence text=" To date, more studies have assessed ritonavir drug-drug interactions with other medications than have assessed cobicistat drug-drug interactions"><entity charOffset="37-46" id="DDI-PubMed.27196356.s7.e0" text="ritonavir" /></sentence><sentence text=" The objective of this article is to review the drug-drug interactions when cobicistat- or ritonavir-boosted elvitegravir, cobicistat, or elvitegravir/cobicistat/emtricitabine/tenofovir are coadministered with antiretroviral therapies or drugs that are either substrates, inducers, or inhibitors of the CYP3A metabolic pathway, as well as with drugs that alter intra-gastric pH or are substrates of P-gp, in order to inform the proper use of elvitegravir/cobicistat/emtricitabine/tenofovir"><entity charOffset="91-100" id="DDI-PubMed.27196356.s8.e0" text="ritonavir" /><entity charOffset="109-121" id="DDI-PubMed.27196356.s8.e1" text="elvitegravir" /><entity charOffset="123-133" id="DDI-PubMed.27196356.s8.e2" text="cobicistat" /><entity charOffset="138-150" id="DDI-PubMed.27196356.s8.e3" text="elvitegravir" /><entity charOffset="151-161" id="DDI-PubMed.27196356.s8.e4" text="cobicistat" /><entity charOffset="162-175" id="DDI-PubMed.27196356.s8.e5" text="emtricitabine" /><entity charOffset="176-185" id="DDI-PubMed.27196356.s8.e6" text="tenofovir" /><entity charOffset="442-454" id="DDI-PubMed.27196356.s8.e7" text="elvitegravir" /><entity charOffset="455-465" id="DDI-PubMed.27196356.s8.e8" text="cobicistat" /><entity charOffset="466-479" id="DDI-PubMed.27196356.s8.e9" text="emtricitabine" /><entity charOffset="480-489" id="DDI-PubMed.27196356.s8.e10" text="tenofovir" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e0" e2="DDI-PubMed.27196356.s8.e0" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e0" e2="DDI-PubMed.27196356.s8.e1" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e0" e2="DDI-PubMed.27196356.s8.e2" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e0" e2="DDI-PubMed.27196356.s8.e3" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e0" e2="DDI-PubMed.27196356.s8.e4" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e0" e2="DDI-PubMed.27196356.s8.e5" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e0" e2="DDI-PubMed.27196356.s8.e6" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e0" e2="DDI-PubMed.27196356.s8.e7" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e0" e2="DDI-PubMed.27196356.s8.e8" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e0" e2="DDI-PubMed.27196356.s8.e9" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e0" e2="DDI-PubMed.27196356.s8.e10" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e1" e2="DDI-PubMed.27196356.s8.e1" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e1" e2="DDI-PubMed.27196356.s8.e2" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e1" e2="DDI-PubMed.27196356.s8.e3" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e1" e2="DDI-PubMed.27196356.s8.e4" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e1" e2="DDI-PubMed.27196356.s8.e5" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e1" e2="DDI-PubMed.27196356.s8.e6" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e1" e2="DDI-PubMed.27196356.s8.e7" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e1" e2="DDI-PubMed.27196356.s8.e8" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e1" e2="DDI-PubMed.27196356.s8.e9" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e1" e2="DDI-PubMed.27196356.s8.e10" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e2" e2="DDI-PubMed.27196356.s8.e2" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e2" e2="DDI-PubMed.27196356.s8.e3" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e2" e2="DDI-PubMed.27196356.s8.e4" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e2" e2="DDI-PubMed.27196356.s8.e5" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e2" e2="DDI-PubMed.27196356.s8.e6" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e2" e2="DDI-PubMed.27196356.s8.e7" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e2" e2="DDI-PubMed.27196356.s8.e8" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e2" e2="DDI-PubMed.27196356.s8.e9" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e2" e2="DDI-PubMed.27196356.s8.e10" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e3" e2="DDI-PubMed.27196356.s8.e3" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e3" e2="DDI-PubMed.27196356.s8.e4" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e3" e2="DDI-PubMed.27196356.s8.e5" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e3" e2="DDI-PubMed.27196356.s8.e6" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e3" e2="DDI-PubMed.27196356.s8.e7" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e3" e2="DDI-PubMed.27196356.s8.e8" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e3" e2="DDI-PubMed.27196356.s8.e9" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e3" e2="DDI-PubMed.27196356.s8.e10" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e4" e2="DDI-PubMed.27196356.s8.e4" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e4" e2="DDI-PubMed.27196356.s8.e5" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e4" e2="DDI-PubMed.27196356.s8.e6" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e4" e2="DDI-PubMed.27196356.s8.e7" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e4" e2="DDI-PubMed.27196356.s8.e8" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e4" e2="DDI-PubMed.27196356.s8.e9" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e4" e2="DDI-PubMed.27196356.s8.e10" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e5" e2="DDI-PubMed.27196356.s8.e5" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e5" e2="DDI-PubMed.27196356.s8.e6" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e5" e2="DDI-PubMed.27196356.s8.e7" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e5" e2="DDI-PubMed.27196356.s8.e8" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e5" e2="DDI-PubMed.27196356.s8.e9" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e5" e2="DDI-PubMed.27196356.s8.e10" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e6" e2="DDI-PubMed.27196356.s8.e6" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e6" e2="DDI-PubMed.27196356.s8.e7" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e6" e2="DDI-PubMed.27196356.s8.e8" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e6" e2="DDI-PubMed.27196356.s8.e9" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e6" e2="DDI-PubMed.27196356.s8.e10" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e7" e2="DDI-PubMed.27196356.s8.e7" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e7" e2="DDI-PubMed.27196356.s8.e8" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e7" e2="DDI-PubMed.27196356.s8.e9" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e7" e2="DDI-PubMed.27196356.s8.e10" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e8" e2="DDI-PubMed.27196356.s8.e8" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e8" e2="DDI-PubMed.27196356.s8.e9" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e8" e2="DDI-PubMed.27196356.s8.e10" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e9" e2="DDI-PubMed.27196356.s8.e9" /><pair ddi="false" e1="DDI-PubMed.27196356.s8.e9" e2="DDI-PubMed.27196356.s8.e10" /></sentence><sentence text=" " /></document>